Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Operating Income (2022 - 2025)

Historic Operating Income for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$8.0 million.

  • CervoMed's Operating Income fell 4906.95% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.2 million, marking a year-over-year decrease of 10200.98%. This contributed to the annual value of -$18.2 million for FY2024, which is 13329.55% down from last year.
  • Per CervoMed's latest filing, its Operating Income stood at -$8.0 million for Q3 2025, which was down 4906.95% from -$6.6 million recorded in Q2 2025.
  • In the past 5 years, CervoMed's Operating Income registered a high of -$904054.0 during Q3 2022, and its lowest value of -$8.0 million during Q3 2025.
  • Over the past 4 years, CervoMed's median Operating Income value was -$2.7 million (recorded in 2023), while the average stood at -$3.7 million.
  • In the last 5 years, CervoMed's Operating Income tumbled by 19590.37% in 2023 and then tumbled by 4906.95% in 2025.
  • CervoMed's Operating Income (Quarter) stood at -$938823.0 in 2022, then plummeted by 164.21% to -$2.5 million in 2023, then tumbled by 191.92% to -$7.2 million in 2024, then decreased by 11.1% to -$8.0 million in 2025.
  • Its Operating Income stands at -$8.0 million for Q3 2025, versus -$6.6 million for Q2 2025 and -$5.3 million for Q1 2025.